Metagen Therapeutics
Latest round
- Series B
Last raised
- Sep 2026
Total raised
- $40M
Investors
- 20
About Metagen Therapeutics
, a pharmaceutical company that engages in the research and development of new drugs and medical treatments using cal microbiota transplantation (FMT). The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis, immuno oncology, and neurodegenerative disease. It leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. Metagen Therapeutics provides microbiome-based healthcare and drug discovery solutions focused on gut bacteria. Its services include fecal microbiota transplantation (FMT) programs, stool donor screening and management platforms, and clinical development of microbiome-derived therapeutics. The company operates stool donation facilities, partners with hospitals for donor-based treatments, and develops innovative pharmaceuticals targeting diseases through microbiome modulation. Additionally, it offers research collaborations and medical services aimed at advancing patient care through microbiome science.
Who invested in Metagen Therapeutics
20 investors across 6 rounds
See all investors in Metagen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Metagen Therapeutics
Who invested in Metagen Therapeutics?
Metagen Therapeutics has 20 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Metagen Therapeutics raised?
Metagen Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Metagen Therapeutics last raise money?
Metagen Therapeutics's most recent round on record is a Series B, in Sep 2026.
What does Metagen Therapeutics do?
, a pharmaceutical company that engages in the research and development of new drugs and medical treatments using cal microbiota transplantation (FMT).
Where is Metagen Therapeutics headquartered?
Metagen Therapeutics is headquartered in Tsuruoka, Japan.
Which VCs invest in companies like Metagen Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Metagen Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Metagen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.